<DOC>
	<DOCNO>NCT01624571</DOCNO>
	<brief_summary>This clinical trial conduct determine optimal dose LD02GIFRO improvement gastrointestinal motility dose group compare effectiveness safety patient undergo colon resection .</brief_summary>
	<brief_title>Study Assess Effect Recovery GI Motility Safety Determine Optimal Dose LD02GIFRO</brief_title>
	<detailed_description />
	<criteria>â‰¥ 20 year Subject schedule partial colon resection primary anastomosis via laparotomy Subject schedule receive primary postoperative pain management intravenous patientcontrolled analgesia ( PCA ) opioids Subject schedule total colectomy , colostomy , ileostomy Subject complete bowel obstruction Subject schedule laparoscopic surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>